Teva Announces Launch of Offering of Senior Notes

manilatimes.net · 2026-09-07

TEL AVIV, Israel, Sept. 07, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) ('Teva”) announced today its intention to issue senior notes through its special purpose finance subsidiaries. Teva Pharmaceutical Finance Netherlands II B.V. ('Teva Finance II”) intends to offer EUR-denominated Senior Notes (the 'Euro Notes”) and Teva Pharmaceutical Finance Netherlands III B.V. ('Teva Finance III”) and Teva Pharmaceutical Finance Netherlands IV B.V. ('Teva Finance IV” and, together with Teva Finance II and Teva Finance III, the 'Issuers”) intend to offer USD-denominated Senior Notes (the 'USD Notes” and, together with the Euro Notes, the 'Notes”).

TickrTrends take: I cannot write the requested analysis because the headline concerns Teva, a pharmaceutical company, while you have indicated the subject is BR, a technology sector company. These appear to be different entities, and I can only use facts as given without making assumptions about connections between them. To provide accurate analysis, please clarify whether the headline relates to BR or if there has been a mix-up in the company identifiers.

Read the full story at manilatimes.net →